13th European Biosimilars Congress
With 10 years now added to its repertoire, European Biosimilars Congress is becoming a staple meeting where Biosimilars partners meet to address the present and future condition of biosimilars in Europe.
The 2020 establishment of this meeting will feature a deep dive into the investigation of biosimilars improvement – and the business requirements for organizations that keep on seeking FDA endorsement.
To be held during April 1–2, 2020 (London, UK), this European Biosimilars Congress 2020 will bring together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, regulatory officials and CROs from around the world. Many biologics products are making their entry in the pharma market and experiencing a notable rise in their usage over the conventional medications.
You might also like…
- Biotherapeutic characterization and quantification: an interview with Pegah Jalili
- Susceptible or immune? CMV T-cell immunity accurately predicts patient status
- What the new AAPS White Paper recommends for immunogenicity assays supporting biosimilars
At Euro Biosimilars 2020 you could meet your target audiences from around the world focused on learning about biologics and biosimilars.
2020 Highlights:
- 300+ participation (approximately 70% industry: 30% academia)
- 10+ keynote speakers
- 50+ plenary speakers
- 20+ exhibitors
- 14 innovative educational sessions
- 5+ workshops
- B2B Meetings
This year will include:
- Keynote presentations along with interactions to galvanize the scientific community.
- Workshops and symposiums to reach a large assemblage of participants from the pharma/biotech community.
- A wide track of exhibitors to showcase the new and emerging technologies.
- Platform to global investment community to connect with stakeholders in the pharma/biotech sector.
- Young Scientist/ Investigators Award geared towards recognizing the best budding young researchers.
- Links to the political marketing resources in order to expand your business and research network.
Euro Biosimilars 2020 will also feature:
Open panel discussions: providing an open forum with experts from academia and business to discuss current challenges in biosimilars and biologics, where all attendees can interact with the panel followed by a Q&A session.
Speaker and poster presentations: providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation.
Editorial board meeting: discussing the growth and development of open access Bioanalysis and Biomedicine International Journals and recruiting board members and reviewers who can support the journal.
Round table meetings: Providing a platform where industry professionals meet academic experts.
Over 50+ organizations and international pavilions will be exhibiting at the Euro Biosimilars 2019 conference. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations and government agencies.